デフォルト表紙
市場調査レポート
商品コード
1428422

生物製剤アウトソーシングの世界市場レポート 2024年

Biologics Outsourcing Global Market Report 2024

出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.49円
生物製剤アウトソーシングの世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

生物製剤アウトソーシングの市場規模は、今後数年間で急速に成長すると予想されています。 2028年には13.1%の年間複合成長率(CAGR)で332億9,000万米ドルに成長すると予想されます。予測期間中に予想される成長は、新興市場の成長、個別化医療の台頭、戦略的提携、生物学的医薬品の特許期限切れに起因すると考えられます。予測期間中に予想される注目すべき動向には、技術の進歩、アウトソーシングの複雑さの増大、バイオシミラー市場の拡大、データ分析の統合、サプライチェーンの回復力強化への注力などが含まれます。

生物製剤アウトソーシング市場は、がん症例数の増加により成長する態勢が整っています。がんは、制御されない細胞増殖を特徴とする多様な病気であり、モノクローナル抗体や免疫療法などの生物学的療法を開発するための専門知識とリソースが必要です。 生物製剤アウトソーシングは、さまざまな種類のがんの診断と治療に不可欠な、これらの治療法の開発、製造、臨床供給に必要なインフラストラクチャを提供するのに不可欠です。たとえば、国立バイオテクノロジー情報センターは、2023年 1月に米国で新たに195万8,310人のがん患者が発生し、がん関連死亡者数は60万9,820人と予測されていると報告しました。がんの有病率は、2040年までに新たに2,950万人に増加し、1,640万人が死亡すると予想されており、がんによってもたらされる増大する課題に対処する上での生物製剤アウトソーシングの役割が強調されています。

生物製剤アウトソーシング市場は、慢性疾患や障害の増加によって支えられると予想されます。慢性疾患には継続的な医師の診察が必要であり、生物学的製剤はそのような複雑な健康問題の管理に効果的であることが証明されています。製薬会社やバイオテクノロジー会社は、標的治療法の開発における専門知識をアウトソーシングする傾向にあります。国立医学図書館は、少なくとも1つの慢性疾患を持つ50歳以上の人口は99.5%増加し、2050年には1億4,266万人に達すると推定しています。さらに、複合疾患を患う人の数は2050年には91.16%増加して1,496万8,000人になると予測されています。この慢性疾患の急増は、複雑な病状の要求を満たす上での生物製剤アウトソーシングの重要性を浮き彫りにしています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の生物製剤アウトソーシング市場の促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の生物製剤アウトソーシングの市場規模実績と成長、2018~2023年
  • 世界の生物製剤アウトソーシング市場規模と成長予測、2023~2028年、2033年

第6章 市場セグメンテーション

  • 世界の生物製剤アウトソーシング市場、製品タイプ別セグメンテーション、実績と予測、2018~2023年、2023~2028年、2033年
  • 抗体
  • 組換え
  • ワクチン
  • タンパク質
  • その他
  • 世界の生物製剤アウトソーシング市場、供給源別セグメンテーション、実績と予測、2018~2023年、2023~2028年、2033年
  • 人間
  • 微生物
  • その他
  • 世界の生物製剤アウトソーシング市場、用途別セグメンテーション、実績と予測、2018~2023年、2023~2028年、2033年
  • 腫瘍学
  • 細胞治療と遺伝子治療
  • 血液と血液関連製品の開発
  • ワクチン開発
  • 幹細胞研究
  • その他
  • 世界の生物製剤アウトソーシング市場、エンドユーザー別セグメンテーション、実績と予測、2018~2023年、2023~2028年、2033年
  • 製薬産業
  • バイオテクノロジー産業
  • 受託開発製造機構(CDMO)

第7章 地域と国の分析

  • 世界の生物製剤アウトソーシング市場、地域別、実績と予測、2018~2023年、2023~2028年、2033年
  • 世界の生物製剤アウトソーシング市場、国別、実績と予測、2018~2023年、2023~2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 生物製剤アウトソーシング市場の競合情勢
  • 生物製剤アウトソーシング市場の企業プロファイル
    • AbbVie Inc.
    • Thermo Fisher Scientific Inc.
    • Boehringer Ingelheim GmbH
    • Lonza Group Ag
    • Catalent Inc.

第31章 その他の大手と革新的な企業

  • Sartorius Stedim Biotech SA
  • Charles River Laboratories International Inc.
  • WuXi Biologics Inc.
  • Samsung Biologics Co. Ltd.
  • Emergent BioSolutions Inc.
  • CordenPharma GmbH
  • Ajinomoto Bio-Pharma Services
  • Syngene International Limited
  • Rentschler Biopharma SE
  • Albany Molecular Research Inc.
  • KBI Biopharma Inc.
  • Fujifilm Diosynth Biotechnologies Inc.
  • Avid Bioservices Inc.
  • BioVectra Inc.
  • ProBioGen AG

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の展望と潜在性分析

第36章 付録

目次
Product Code: r14267

Biologics outsourcing in the pharmaceutical industry involves pharmaceutical companies collaborating with external vendors or contract manufacturing organizations (CMOs) to delegate different aspects of biologic drug development, manufacturing, and supply chain management. This strategic approach is employed for various purposes within the pharmaceutical sector, specifically in relation to the development, manufacturing, and management of biological drugs.

The primary product types associated with biologics outsourcing include antibodies, recombinants, vaccines, proteins, and others. Antibodies are immune system-produced defense proteins, also known as antigens, formed in response to the presence of foreign material. These biologics can be derived from human, microbial, and other sources and find applications in areas such as oncology, cellular and gene therapy, blood and blood-related product development, vaccine development, stem cell research, among others. Biologics outsourcing is utilized by diverse end users, including pharmaceutical industries, biotechnology industries, and contract development and manufacturing organizations (CDMO).

The biologics outsourcing market research report is one of a series of new reports from The Business Research Company that provides biologics outsourcing market statistics, including the biologics outsourcing industry's global market size, regional shares, competitors with a biologics outsourcing market share, detailed biologics outsourcing market segments, market trends and opportunities, and any further data you may need to thrive in the biologics outsourcing industry. This biologics outsourcing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The biologics outsourcing market size has grown rapidly in recent years. It will grow from $17.74 billion in 2023 to $20.33 billion in 2024 at a compound annual growth rate (CAGR) of 14.6%. The growth observed in the historical period can be attributed to the increase in research and development (R&D) costs, regulatory pressure, a demand for specialized expertise, and globalization.

The biologics outsourcing market size is expected to see rapid growth in the next few years. It will grow to $33.29 billion in 2028 at a compound annual growth rate (CAGR) of 13.1%. The anticipated growth in the forecast period can be attributed to the growth of emerging markets, the rise of personalized medicine, strategic alliances, and the expiration of patents for biological drugs. Notable trends expected in the forecast period include advancements in technology, increased complexity in outsourcing, the expansion of the biosimilars market, integration of data analytics, and a focus on enhancing supply chain resilience.

The biologics outsourcing market is poised for growth, driven by the increasing number of cancer cases. Cancer, a diverse group of illnesses characterized by uncontrolled cell growth, demands specialized expertise and resources for developing biologic therapies such as monoclonal antibodies and immunotherapies. Biologics outsourcing is integral in providing the necessary infrastructure for the development, manufacturing, and clinical supply of these therapies, crucial for diagnosing and treating various cancer types. For instance, the National Center for Biotechnology Information reported 1,958,310 new cancer cases in the United States in January 2023, with a projected 609,820 cancer-related deaths. The prevalence of cancer is expected to escalate to 29.5 million new cases and 16.4 million deaths by 2040, emphasizing the role of biologics outsourcing in addressing the growing challenges posed by cancer.

The biologics outsourcing market is anticipated to be supported by the rise in chronic diseases and disabilities. Chronic conditions necessitate ongoing medical attention, and biologics prove effective in managing such complex health issues. Pharmaceutical and biotechnology companies are increasingly turning to outsourcing for specialized expertise in developing targeted treatments. The National Library of Medicine estimates a 99.5% increase in people aged 50 and older with at least one chronic illness, reaching 142.66 million in 2050. Additionally, the number of individuals with multimorbidity is projected to rise by 91.16% to 14.968 million in 2050. This surge in chronic diseases underscores the significance of biologics outsourcing in meeting the demands of intricate medical conditions.

A notable trend in the biologics outsourcing market is the emphasis on developments in biologics. Major companies are leveraging new technologies to sustain their market positions. For instance, Abzena, Alira Health, and Oncodesign launched DRIVE-Biologics, a consortium dedicated to biologic drug discovery and development programs. This collaborative effort streamlines information sharing and program deliverables, minimizing risks associated with biologics development. The partnership covers all stages, from biological discovery to clinical and commercial manufacturing, reflecting the commitment to advancing the field of biologics.

Companies in the biologics outsourcing market are focusing on establishing new Contract Development and Manufacturing Organizations (CDMOs) to maintain their market presence. Tanvex BioPharma USA Inc. introduced Tanvex CDMO in October 2023, offering end-to-end services for the development and manufacturing of biologics. Located in San Diego's biotech hub, Tanvex CDMO features state-of-the-art facilities, including R&D centers, GMP manufacturing suites, QC laboratories, and a GMP warehouse. With a proven track record, Tanvex CDMO aims to support early-stage companies in advancing biologics from conceptualization to commercialization.

In June 2022, Asahi Kasei Medical acquired Bionova Scientific LLC, expanding its bioprocess business to include biopharmaceutical contract development and manufacturing. Bionova Scientific LLC, a biologics CDMO, enhances Asahi Kasei Medical's capabilities in biologic drug development, manufacturing, and supply chain management, contributing to the broader landscape of biologics outsourcing.

Major companies operating in the biologics outsourcing market report are AbbVie Inc., Thermo Fisher Scientific Inc., Boehringer Ingelheim GmbH, Lonza Group Ag, Catalent Inc., Sartorius Stedim Biotech S.A., Charles River Laboratories International Inc., WuXi Biologics Inc., Samsung Biologics Co. Ltd., Emergent BioSolutions Inc., CordenPharma GmbH, Ajinomoto Bio-Pharma Services, Syngene International Limited, Rentschler Biopharma SE, Albany Molecular Research Inc., KBI Biopharma Inc., Fujifilm Diosynth Biotechnologies Inc., Avid Bioservices Inc., BioVectra Inc., ProBioGen AG, ABL Inc., Vibalogics GmbH, JHL Biotech Inc., Goodwin Biotechnology Inc., Crown Bioscience Inc., Cytovance Biologics Inc., LakePharma Inc., AGC Biologics GmbH, Biomay AG, Polpharma Biologics S.A.

North America was the largest region in the biologics outsourcing market in 2023. The regions covered in the biologics outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the biologics outsourcing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The biologics outsourcing market includes revenues earned by entities through cell line development, contract research services, and optimization. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biologics Outsourcing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biologics outsourcing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biologics outsourcing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The biologics outsourcing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Product Type: Antibodies; Recombinant; Vaccines; Protein; Other Products
  • 2) By Source: Human; Microbial; Other Source
  • 3) By Application: Oncology; Cellular and Gene Therapy; Blood And Blood-Related Products Development; Vaccine Development; Stem Cell Research; Other Applications
  • 4) By End User: Pharmaceutical Industries; Biotechnology Industries; Contract Development And Manufacturing Organization(CDMO)
  • Companies Mentioned: AbbVie Inc.; Thermo Fisher Scientific Inc.; Boehringer Ingelheim GmbH; Lonza Group Ag; Catalent Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Biologics Outsourcing Market Characteristics

3. Biologics Outsourcing Market Trends And Strategies

4. Biologics Outsourcing Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Biologics Outsourcing Market Size and Growth

  • 5.1. Global Biologics Outsourcing Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Biologics Outsourcing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Biologics Outsourcing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Biologics Outsourcing Market Segmentation

  • 6.1. Global Biologics Outsourcing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Antibodies
  • Recombinant
  • Vaccines
  • Protein
  • Other Products
  • 6.2. Global Biologics Outsourcing Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Human
  • Microbial
  • Other Source
  • 6.3. Global Biologics Outsourcing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oncology
  • Cellular and Gene Therapy
  • Blood And Blood-Related Products Development
  • Vaccine Development
  • Stem Cell Research
  • Other Applications
  • 6.4. Global Biologics Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Pharmaceutical Industries
  • Biotechnology Industries
  • Contract Development And Manufacturing Organization(CDMO)

7. Biologics Outsourcing Market Regional And Country Analysis

  • 7.1. Global Biologics Outsourcing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Biologics Outsourcing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Biologics Outsourcing Market

  • 8.1. Asia-Pacific Biologics Outsourcing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Biologics Outsourcing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Biologics Outsourcing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Biologics Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Biologics Outsourcing Market

  • 9.1. China Biologics Outsourcing Market Overview
  • 9.2. China Biologics Outsourcing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Biologics Outsourcing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Biologics Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Biologics Outsourcing Market

  • 10.1. India Biologics Outsourcing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Biologics Outsourcing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Biologics Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Biologics Outsourcing Market

  • 11.1. Japan Biologics Outsourcing Market Overview
  • 11.2. Japan Biologics Outsourcing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Biologics Outsourcing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Biologics Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Biologics Outsourcing Market

  • 12.1. Australia Biologics Outsourcing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Biologics Outsourcing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Biologics Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Biologics Outsourcing Market

  • 13.1. Indonesia Biologics Outsourcing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Biologics Outsourcing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Biologics Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Biologics Outsourcing Market

  • 14.1. South Korea Biologics Outsourcing Market Overview
  • 14.2. South Korea Biologics Outsourcing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Biologics Outsourcing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Biologics Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Biologics Outsourcing Market

  • 15.1. Western Europe Biologics Outsourcing Market Overview
  • 15.2. Western Europe Biologics Outsourcing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Biologics Outsourcing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Biologics Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Biologics Outsourcing Market

  • 16.1. UK Biologics Outsourcing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Biologics Outsourcing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Biologics Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Biologics Outsourcing Market

  • 17.1. Germany Biologics Outsourcing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Biologics Outsourcing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Biologics Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Biologics Outsourcing Market

  • 18.1. France Biologics Outsourcing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Biologics Outsourcing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Biologics Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Biologics Outsourcing Market

  • 19.1. Italy Biologics Outsourcing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Biologics Outsourcing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Biologics Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Biologics Outsourcing Market

  • 20.1. Spain Biologics Outsourcing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Biologics Outsourcing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Biologics Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Biologics Outsourcing Market

  • 21.1. Eastern Europe Biologics Outsourcing Market Overview
  • 21.2. Eastern Europe Biologics Outsourcing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Biologics Outsourcing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Biologics Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Biologics Outsourcing Market

  • 22.1. Russia Biologics Outsourcing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Biologics Outsourcing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Biologics Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Biologics Outsourcing Market

  • 23.1. North America Biologics Outsourcing Market Overview
  • 23.2. North America Biologics Outsourcing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Biologics Outsourcing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Biologics Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Biologics Outsourcing Market

  • 24.1. USA Biologics Outsourcing Market Overview
  • 24.2. USA Biologics Outsourcing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Biologics Outsourcing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Biologics Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Biologics Outsourcing Market

  • 25.1. Canada Biologics Outsourcing Market Overview
  • 25.2. Canada Biologics Outsourcing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Biologics Outsourcing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Biologics Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Biologics Outsourcing Market

  • 26.1. South America Biologics Outsourcing Market Overview
  • 26.2. South America Biologics Outsourcing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Biologics Outsourcing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Biologics Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Biologics Outsourcing Market

  • 27.1. Brazil Biologics Outsourcing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Biologics Outsourcing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Biologics Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Biologics Outsourcing Market

  • 28.1. Middle East Biologics Outsourcing Market Overview
  • 28.2. Middle East Biologics Outsourcing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Biologics Outsourcing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Biologics Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Biologics Outsourcing Market

  • 29.1. Africa Biologics Outsourcing Market Overview
  • 29.2. Africa Biologics Outsourcing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Biologics Outsourcing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Biologics Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Biologics Outsourcing Market Competitive Landscape And Company Profiles

  • 30.1. Biologics Outsourcing Market Competitive Landscape
  • 30.2. Biologics Outsourcing Market Company Profiles
    • 30.2.1. AbbVie Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Thermo Fisher Scientific Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Boehringer Ingelheim GmbH
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Lonza Group Ag
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Catalent Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Biologics Outsourcing Market Other Major And Innovative Companies

  • 31.1. Sartorius Stedim Biotech S.A.
  • 31.2. Charles River Laboratories International Inc.
  • 31.3. WuXi Biologics Inc.
  • 31.4. Samsung Biologics Co. Ltd.
  • 31.5. Emergent BioSolutions Inc.
  • 31.6. CordenPharma GmbH
  • 31.7. Ajinomoto Bio-Pharma Services
  • 31.8. Syngene International Limited
  • 31.9. Rentschler Biopharma SE
  • 31.10. Albany Molecular Research Inc.
  • 31.11. KBI Biopharma Inc.
  • 31.12. Fujifilm Diosynth Biotechnologies Inc.
  • 31.13. Avid Bioservices Inc.
  • 31.14. BioVectra Inc.
  • 31.15. ProBioGen AG

32. Global Biologics Outsourcing Market Competitive Benchmarking

33. Global Biologics Outsourcing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Biologics Outsourcing Market

35. Biologics Outsourcing Market Future Outlook and Potential Analysis

  • 35.1 Biologics Outsourcing Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Biologics Outsourcing Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Biologics Outsourcing Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer